BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 33731862)

  • 1. Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates.
    Kim SY; Kim DH; Moon SM; Song JY; Huh HJ; Lee NY; Shin SJ; Koh WJ; Jhun BW
    Sci Rep; 2021 Mar; 11(1):6108. PubMed ID: 33731862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
    Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates.
    Brown-Elliott BA; Iakhiaeva E; Griffith DE; Woods GL; Stout JE; Wolfe CR; Turenne CY; Wallace RJ
    J Clin Microbiol; 2013 Oct; 51(10):3389-94. PubMed ID: 23946523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
    J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic mutations in linezolid-resistant Mycobacterium avium complex and Mycobacterium abscessus clinical isolates.
    Kim SY; Jhun BW; Moon SM; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Diagn Microbiol Infect Dis; 2019 May; 94(1):38-40. PubMed ID: 30581010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand.
    Sirichoat A; Kaewprasert O; Hinwan Y; Faksri K
    PLoS One; 2023; 18(11):e0294677. PubMed ID: 37992075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
    Fröberg G; Maurer FP; Chryssanthou E; Fernström L; Benmansour H; Boarbi S; Mengshoel AT; Keller PM; Viveiros M; Machado D; Fitzgibbon MM; Mok S; Werngren J; Cirillo DM; Alcaide F; Hyyryläinen HL; Aubry A; Andres S; Nadarajan D; Svensson E; Turnidge J; Giske CG; Kahlmeter G; Cambau E; van Ingen J; Schön T;
    Clin Microbiol Infect; 2023 Jun; 29(6):758-764. PubMed ID: 36813087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in
    Kim SY; Jhun BW; Moon SM; Shin SH; Jeon K; Kwon OJ; Yoo IY; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Suh GY; Koh WJ
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility and molecular characterization of Mycobacterium intracellulare in China.
    Zhao X; Wang Y; Pang Y
    Infect Genet Evol; 2014 Oct; 27():332-8. PubMed ID: 25131955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease by Single Bacterial Isolation Plus Anti-GPL-Core IgA Antibody.
    Kawasaki T; Kitada S; Fukushima K; Akiba E; Haduki K; Saito H; Nitta T; Kawano A; Miyazaki A; Nii T; Kuge T; Koba T; Matsuki T; Tsujino K; Miki K; Maekura R; Kida H
    Microbiol Spectr; 2022 Feb; 10(1):e0140621. PubMed ID: 34985326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the Genotype and Drug Susceptibilities between Mycobacterium avium and Mycobacterium intracellulare in China.
    Zheng HW; Pang Y; He GX; Song YY; Zhao YL
    Biomed Environ Sci; 2017 Jul; 30(7):517-525. PubMed ID: 28756811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and molecular characterisation of amikacin-resistant Mycobacterium abscessus isolated from patients with pulmonary disease.
    Wu M; Li B; Guo Q; Xu L; Zou Y; Zhang Y; Zhan M; Xu B; Ye M; Yu F; Zhang Z; Chu H
    J Glob Antimicrob Resist; 2019 Dec; 19():188-191. PubMed ID: 31121335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease.
    Fujiwara K; Uesugi F; Furuuchi K; Tanaka Y; Yoshiyama T; Saotome M; Ohta K; Mitarai S; Morimoto K
    Microbiol Spectr; 2021 Dec; 9(3):e0192821. PubMed ID: 34878300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease.
    Kim DH; Kim BG; Kim SY; Huh HJ; Lee NY; Koh WJ; Kim H; Kwon OJ; Jhun BW
    J Clin Med; 2021 Oct; 10(19):. PubMed ID: 34640599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania.
    Maya TG; Komba EV; Mensah GI; Mbelele PM; Mpagama SG; Mfinanga SG; Addo KK; Kazwala RR
    PLoS One; 2022; 17(3):e0265358. PubMed ID: 35324922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bedaquiline susceptibility testing of Mycobacterium abscessus complex and Mycobacterium avium complex: A meta-analysis study.
    Wang M; Men P; Zhang W; Wu J; Gu Y; Wang F; Huang H; Yu X; Duan H
    J Glob Antimicrob Resist; 2024 Jun; 37():135-140. PubMed ID: 38561143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Whole Genome Sequencing for Clarithromycin and Amikacin Resistance Prediction and Subspecies Identification of Mycobacterium abscessus.
    Realegeno S; Mirasol R; Garner OB; Yang S
    J Mol Diagn; 2021 Nov; 23(11):1460-1467. PubMed ID: 34454109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease.
    Jhun BW; Yang B; Moon SM; Lee H; Park HY; Jeon K; Kwon OJ; Ahn J; Moon IJ; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating amikacin minimum inhibitory concentration in trailing growth for Mycobacterium avium complex.
    Park B; Shim TS; Jo KW; Won EJ; Kim MN; Sung H
    Tuberculosis (Edinb); 2023 Dec; 143():102427. PubMed ID: 37918057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan.
    Yamaba Y; Ito Y; Suzuki K; Kikuchi T; Ogawa K; Fujiuchi S; Hasegawa N; Kurashima A; Higuchi T; Uchiya KI; Watanabe A; Niimi A
    J Infect Chemother; 2019 Dec; 25(12):995-1000. PubMed ID: 31239192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.